{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:24:55Z","timestamp":1791804295975,"version":"4.3.4"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05000-w","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:16:17Z","timestamp":1775571377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Innovative strategies for immune thrombocytopenia treatment: immunomodulatory mechanisms and clinical potential of mesenchymal stem cells"],"prefix":"10.1186","volume":"17","author":[{"given":"Xin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"23","key":"5000_CR1","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa2400409","volume":"390","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xu Y, Li H, et al. A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia. N Engl J Med. 2024;390(23):2178\u201390.","journal-title":"N Engl J Med"},{"key":"5000_CR2","doi-asserted-by":"publisher","first-page":"1499014","DOI":"10.3389\/fimmu.2025.1499014","volume":"16","author":"S Bu","year":"2025","unstructured":"Bu S, Liu M, Yang L, et al. The Function of T Cells in Immune Thrombocytopenia. Front Immunol. 2025;16:1499014.","journal-title":"Front Immunol"},{"issue":"11","key":"5000_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/1750743X.2025.2545170","volume":"17","author":"DJ Kuter","year":"2025","unstructured":"Kuter DJ, Ghanima W. Evaluating Rilzabrutinib in the Treatment of Immune Thrombocytopenia. Immunotherapy. 2025;17(11):767\u201382.","journal-title":"Immunotherapy"},{"issue":"1","key":"5000_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13287-024-03885-z","volume":"15","author":"S Zhidu","year":"2024","unstructured":"Zhidu S, Ying T, Rui J, et al. Translational Potential of Mesenchymal Stem Cells in Regenerative Therapies for Human Diseases: Challenges and Opportunities. Stem Cell Res Ther. 2024;15(1):266.","journal-title":"Stem Cell Res Ther"},{"key":"5000_CR5","doi-asserted-by":"crossref","unstructured":"Xu Q, Hou W, Zhao B, et al. Mesenchymal Stem Cells Lineage and Their Role in Disease Development. Molecular Medicine. Volume 30. Cambridge, Mass.); 2024. p. 207. 1.","DOI":"10.1186\/s10020-024-00967-9"},{"issue":"4","key":"5000_CR6","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/bjh.19709","volume":"205","author":"Z Liang","year":"2024","unstructured":"Liang Z, Zhang G, Gan G, et al. Activation of the HMGB1-TLR4 Pathway Impacts the Functionality of Bone Marrow Mesenchymal Stem Cells and Disrupts Macrophage Polarization in Immune Thrombocytopenia. Br J Haematol. 2024;205(4):1516\u201331.","journal-title":"Br J Haematol"},{"issue":"21\u201322","key":"5000_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/scd.2023.0154","volume":"32","author":"Z Liang","year":"2023","unstructured":"Liang Z, Zhang G, Gan G, et al. Mesenchymal Stromal Cells Regulate M1\/M2 Macrophage Polarization in Mice with Immune Thrombocytopenia. Stem Cells Dev. 2023;32(21\u201322):703\u201314.","journal-title":"Stem Cells Dev"},{"issue":"8","key":"5000_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/cells11081339","volume":"11","author":"B Zoehler","year":"2022","unstructured":"Zoehler B, Fracaro L, Boldrini-Leite LM, et al. HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy. Cells. 2022;11(8):1339.","journal-title":"Cells"},{"issue":"3","key":"5000_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/JLB.3MR0321-766R","volume":"110","author":"L Shang","year":"2021","unstructured":"Shang L, Shao J, Ge S. Immunomodulatory Functions of Oral Mesenchymal Stem Cells: Novel Force for Tissue Regeneration and Disease Therapy. J Leukoc Biol. 2021;110(3):539\u201352.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"5000_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, et al. Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"3","key":"5000_CR11","first-page":"787","volume":"12","author":"R Lu","year":"2020","unstructured":"Lu R, Wang Q, Li J, et al. P27 Deletion Enhances Hematopoiesis by Paracrine Action of IL22 Secreted from Bone Marrow Mesenchymal Stem Cells. Am J Translational Res. 2020;12(3):787\u201399.","journal-title":"Am J Translational Res"},{"key":"5000_CR12","doi-asserted-by":"crossref","unstructured":"Luo W, Liang P, Zhao T, et al. Reversely Immortalized Mouse Salivary Gland Cells Presented a Promising Metabolic and Fibrotic Response upon BMP9\/Gdf2 Stimulation. Volume 27. Cellular & Molecular Biology Letters; 2022. p. 46. 1.","DOI":"10.1186\/s11658-022-00333-9"},{"issue":"3","key":"5000_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbrc.2020.02.125","volume":"525","author":"M Yang","year":"2020","unstructured":"Yang M, Lin J, Tang J, et al. Decreased Immunomodulatory and Secretory Capability of Aging Human Umbilical Cord Mesenchymal Stem Cells in Vitro. Biochem Biophys Res Commun. 2020;525(3):633\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"5000_CR14","doi-asserted-by":"publisher","first-page":"FSO794","DOI":"10.2144\/fsoa-2021-0155","volume":"8","author":"D Bates","year":"2022","unstructured":"Bates D, Vivian D, Freitag J, et al. Low-Dose Mesenchymal Stem Cell Therapy for Discogenic Pain: Safety and Efficacy Results from a 1-Year Feasibility Study. Future Sci OA. 2022;8(5):FSO794.","journal-title":"Future Sci OA"},{"key":"5000_CR15","doi-asserted-by":"crossref","unstructured":"Huang CY. Biology of Extracellular Vesicles from Mesenchymal Stem Cells[G]\/\/, Nguyen LT, Forsyth NR, Heke M. Cell Therapy: Stem Cells and Regenerative Medicine. Singapore: Springer Nature, 2025: 105\u2013139.","DOI":"10.1007\/978-981-96-1261-1_6"},{"issue":"6","key":"5000_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1515\/oncologie-2023-0278","volume":"25","author":"MiR-100-5p Transfected","year":"2023","unstructured":"MiR-100-5p Transfected. MSCs-Derived Exosomes Can Suppress NSCLC Progression via PI3K-AKT-mTOR. Oncologie. 2023;25(6):705\u201315.","journal-title":"Oncologie"},{"issue":"1","key":"5000_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12951-024-03088-x","volume":"23","author":"AI Figueroa-Vald\u00e9s","year":"2025","unstructured":"Figueroa-Vald\u00e9s AI, Luz-Crawford P, Herrera-Luna Y, et al. Clinical-Grade Extracellular Vesicles Derived from Umbilical Cord Mesenchymal Stromal Cells: Preclinical Development and First-in-Human Intra-Articular Validation as Therapeutics for Knee Osteoarthritis. J Nanobiotechnol. 2025;23(1):13.","journal-title":"J Nanobiotechnol"},{"key":"5000_CR18","doi-asserted-by":"crossref","unstructured":"E RF. F, S V, Hydrogel Encapsulation of Mesenchymal Stem Cells-Derived Extracellular Vesicles as a Novel Therapeutic Approach in Cancer Therapy. Biochimica et biophysica acta. Reviews on cancer. Biochim Biophys Acta Rev Cancer, 2024, 1879(5).","DOI":"10.1016\/j.bbcan.2024.189177"},{"issue":"1","key":"5000_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","volume":"14","author":"T Zhou","year":"2021","unstructured":"Zhou T, Yuan Z, Weng J, et al. Challenges and Advances in Clinical Applications of Mesenchymal Stromal Cells. J Hematol Oncol. 2021;14(1):24.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"5000_CR20","first-page":"313","volume":"80","author":"H Amirhossein","year":"2025","unstructured":"Amirhossein H, Arash A, Aida N, et al. Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering. Arch Razi Inst. 2025;80(2):313\u201324.","journal-title":"Arch Razi Inst"},{"key":"5000_CR21","doi-asserted-by":"crossref","unstructured":"Nauta AJ, Kruisselbrink AB, Lurvink E et al. Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells. Journal of Immunology (Baltimore, Md.: 1950), 2006, 177(4): 2080\u20132087.","DOI":"10.4049\/jimmunol.177.4.2080"},{"issue":"3","key":"5000_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5966\/sctm.2015-0179","volume":"5","author":"F Ke","year":"2016","unstructured":"Ke F, Zhang L, Liu Z, et al. Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation. Stem Cells Translational Med. 2016;5(3):301\u201313.","journal-title":"Stem Cells Translational Med"},{"issue":"3","key":"5000_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12026-014-8612-2","volume":"61","author":"X Liu","year":"2015","unstructured":"Liu X, Ren S, Qu X, et al. Mesenchymal Stem Cells Inhibit Th17 Cells Differentiation via IFN-\u03b3-Mediated SOCS3 Activation. Immunol Res. 2015;61(3):219\u201329.","journal-title":"Immunol Res"},{"key":"5000_CR24","first-page":"e08645","volume-title":"Mesenchymal Stem Cell-Derived Extracellular Vesicles Modulate the Course of Peritoneal Inflammation Through Metabolic and Epigenetic Regulation","author":"Q Huang","year":"2025","unstructured":"Huang Q, Sun Y, Kuang P, et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles Modulate the Course of Peritoneal Inflammation Through Metabolic and Epigenetic Regulation. Baden-Wurttemberg, Germany): Advanced Science (Weinheim; 2025. p. e08645."},{"issue":"8","key":"5000_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/stem.3185","volume":"38","author":"RI Azevedo","year":"2020","unstructured":"Azevedo RI, Minskaia E, Fernandes-Platzgummer A, et al. Mesenchymal Stromal Cells Induce Regulatory T Cells via Epigenetic Conversion of Human Conventional CD4 T Cells in Vitro. Stem Cells. 2020;38(8):1007\u201319.","journal-title":"Stem Cells"},{"key":"5000_CR26","doi-asserted-by":"crossref","unstructured":"Xiao X, Xu M, Yu H, et al. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Oxidative Stress-Induced Senescence in Endothelial Cells via Regulation of miR-146a\/Src. Volume 6. Signal Transduction and Targeted Therapy; 2021. p. 354. 1.","DOI":"10.1038\/s41392-021-00765-3"},{"key":"5000_CR27","doi-asserted-by":"crossref","unstructured":"E RF et al. F, S V,. Cytokines Secreted from Bone Marrow-Derived Mesenchymal Stem Cells Promote Apoptosis of CD34\u2009+\u2009Leukemic Stem Cells as Anti-Cancer Therapy. Regenerative therapy, Regen Ther, 2024, 26.","DOI":"10.1016\/j.reth.2024.08.008"},{"issue":"6","key":"5000_CR28","doi-asserted-by":"publisher","first-page":"152765","DOI":"10.1016\/j.imbio.2023.152765","volume":"228","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Yang X, Meng Q, et al. Adipose Tissue-Derived Mesenchymal Stromal Cells Attenuate Acute Lung Injury Induced by Trauma and Haemorrhagic Shock. Immunobiology. 2023;228(6):152765.","journal-title":"Immunobiology"},{"key":"5000_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.reth.2025.10.001","volume":"30","author":"M Mendiratta","year":"2025","unstructured":"Mendiratta M, Mendiratta M, Mohanty S, et al. Dose-Response Immunomodulatory Effects of Mesenchymal Stem Cell-Derived Culture-Conditioned Media in Acute Graft-versus-Host Disease. Regenerative Therapy. 2025;30:868\u201374.","journal-title":"Regenerative Therapy"},{"key":"5000_CR30","doi-asserted-by":"crossref","unstructured":"L Z, C L, Y W, et al. Efficacy and Safety of Mesenchymal Stromal Cell Transplantation in the Treatment of Autoimmune and Rheumatic Immune Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Stem cell research & therapy, Stem Cell Res Ther, 2025, 16(1).","DOI":"10.1186\/s13287-025-04184-x"},{"key":"5000_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fcell.2019.00285","volume":"7","author":"RJ Cheng","year":"2019","unstructured":"Cheng RJ, Xiong AJ, Li YH, et al. Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients. Front Cell Dev Biology. 2019;7:285.","journal-title":"Front Cell Dev Biology"},{"key":"5000_CR32","doi-asserted-by":"crossref","unstructured":"T J, S S, R T, et al. Immunoregulatory Orchestrations in Osteoarthritis and Mesenchymal Stromal Cells for Therapy. Journal of orthopaedic translation. J Orthop Translat, 2025, 55.","DOI":"10.1016\/j.jot.2025.08.009"},{"key":"5000_CR33","doi-asserted-by":"crossref","unstructured":"Luz-Crawford P, Tejedor G, Mausset-Bonnefont AL, et al. Glucocorticoid-Induced Leucine Zipper Governs the Therapeutic Potential of Mesenchymal Stem Cells by Inducing a Switch from Pathogenic to Regulatory Th17 Cells in a Mouse Model of Collagen-Induced Arthritis. Volume 67. Arthritis & Rheumatology; 2015. pp. 1514\u201324. (Hoboken, N.J.). 6.","DOI":"10.1002\/art.39069"},{"issue":"8","key":"5000_CR34","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J, et al. Umbilical Cord Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus. Arthritis Rheum. 2010;62(8):2467\u201375.","journal-title":"Arthritis Rheum"},{"key":"5000_CR35","doi-asserted-by":"crossref","unstructured":"Kamen DL, Wallace C, Li Z, et al. Safety, Immunological Effects and Clinical Response in a Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells in Patients with Treatment Refractory SLE. Volume 9. Lupus Science & Medicine; 2022. p. e000704. 1.","DOI":"10.1136\/lupus-2022-000704"},{"key":"5000_CR36","doi-asserted-by":"crossref","unstructured":"Shimizu Y, Ntege EH, Azuma C et al. Management of Rheumatoid Arthritis: Possibilities and Challenges of Mesenchymal Stromal\/Stem Cell-Based Therapies. Cells, 2023, 12(14): 1905.","DOI":"10.3390\/cells12141905"},{"issue":"5","key":"5000_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","volume":"65","author":"D Garcia-Olmo","year":"2022","unstructured":"Garcia-Olmo D, Gilaberte I, Binek M, et al. Follow-up Study to Evaluate the Long-Term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn\u2019s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial. Dis Colon Rectum. 2022;65(5):713\u201320.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"5000_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5114\/reum.2020.99995","volume":"58","author":"DW Dudek","year":"2020","unstructured":"Dudek DW, Walczuk E, Wajda A, et al. Mesenchymal Stem Cells in Systemic Sclerosis Therapy. Reumatologia. 2020;58(5):324\u201330.","journal-title":"Reumatologia"},{"issue":"1","key":"5000_CR39","first-page":"24","volume":"8","author":"A Dulamea","year":"2015","unstructured":"Dulamea A. Mesenchymal Stem Cells in Multiple Sclerosis - Translation to Clinical Trials. J Med Life. 2015;8(1):24\u20137.","journal-title":"J Med Life"},{"issue":"1","key":"5000_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13287-024-03765-6","volume":"15","author":"VK Harris","year":"2024","unstructured":"Harris VK, Stark J, Williams A, et al. Efficacy of Intrathecal Mesenchymal Stem Cell-Neural Progenitor Therapy in Progressive MS: Results from a Phase II, Randomized, Placebo-Controlled Clinical Trial. Stem Cell Res Ther. 2024;15(1):151.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5000_CR41","doi-asserted-by":"publisher","first-page":"13521","DOI":"10.1038\/s41598-023-40802-5","volume":"13","author":"F Li","year":"2023","unstructured":"Li F, Lu J, Shi X, et al. Effect of Adipose Tissue-Derived Stem Cells Therapy on Clinical Response in Patients with Primary Sjogren\u2019s Syndrome. Sci Rep. 2023;13(1):13521.","journal-title":"Sci Rep"},{"issue":"15","key":"5000_CR42","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu J, Wang D, Liu D, et al. Allogeneic Mesenchymal Stem Cell Treatment Alleviates Experimental and Clinical Sj\u00f6gren Syndrome. Blood. 2012;120(15):3142\u201351.","journal-title":"Blood"},{"issue":"1","key":"5000_CR43","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-022-02941-w","volume":"13","author":"M Izadi","year":"2022","unstructured":"Izadi M, Sadr Hashemi Nejad A, Moazenchi M, et al. Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type-1 Diabetes Patients: A Phase I\/II Randomized Placebo-Controlled Clinical Trial. Stem Cell Res Ther. 2022;13(1):264.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5000_CR44","first-page":"102","volume":"9","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xu Y, Chi Y, et al. Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Refractory Immune Thrombocytopenia: A Prospective, Single Arm, Phase I Trial. Signal Transduction and Targeted Therapy. Nat Publishing Group. 2024;9(1):102.","journal-title":"Nat Publishing Group"},{"issue":"6","key":"5000_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3109\/14653240903051558","volume":"11","author":"JA P\u00e9rez-Sim\u00f3n","year":"2009","unstructured":"P\u00e9rez-Sim\u00f3n JA, Tabera S, Sarasquete ME, et al. Mesenchymal Stem Cells Are Functionally Abnormal in Patients with Immune Thrombocytopenic Purpura. Cytotherapy. 2009;11(6):698\u2013705.","journal-title":"Cytotherapy"},{"issue":"1","key":"5000_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13287-017-0558-6","volume":"8","author":"Y Petrenko","year":"2017","unstructured":"Petrenko Y, Sykov\u00e1 E, Kubinov\u00e1 \u0160. The Therapeutic Potential of Three-Dimensional Multipotent Mesenchymal Stromal Cell Spheroids. Stem Cell Res Ther. 2017;8(1):94.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5000_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-019-1224-y","volume":"10","author":"N Noronha","year":"2019","unstructured":"Noronha N, de Mizukami C, Cali\u00e1ri-Oliveira A. Priming Approaches to Improve the Efficacy of Mesenchymal Stromal Cell-Based Therapies. Stem Cell Res Ther. 2019;10(1):131.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5000_CR48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s13287-023-03579-y","volume":"14","author":"T Tolstova","year":"2023","unstructured":"Tolstova T, Dotsenko E, Kozhin P, et al. The Effect of TLR3 Priming Conditions on MSC Immunosuppressive Properties. Stem Cell Res Ther. 2023;14(1):344.","journal-title":"Stem Cell Res Ther"},{"key":"5000_CR49","doi-asserted-by":"crossref","unstructured":"Pittenger MF, Mackay AM, Beck SC, et al. Multilineage Potential of Adult Human Mesenchymal Stem Cells. Volume 284. Science; 1999. pp. 143\u20137. (New York, N.Y.). 5411.","DOI":"10.1126\/science.284.5411.143"},{"issue":"31","key":"5000_CR50","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1073\/pnas.1008117107","volume":"107","author":"TJ Bartosh","year":"2010","unstructured":"Bartosh TJ, Yl\u00f6stalo JH, Mohammadipoor A, et al. Aggregation of Human Mesenchymal Stromal Cells (MSCs) into 3D Spheroids Enhances Their Antiinflammatory Properties. Proc Natl Acad Sci USA. 2010;107(31):13724\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5000_CR51","doi-asserted-by":"crossref","unstructured":"Cimino M, Gon\u00e7alves RM, Barrias CC et al. Xeno-Free Strategies for Safe Human Mesenchymal Stem\/Stromal Cell Expansion: Supplements and Coatings. Stem Cells International, 2017, 2017: 6597815.","DOI":"10.1155\/2017\/6597815"},{"issue":"1","key":"5000_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13287-018-1007-x","volume":"9","author":"B Antebi","year":"2018","unstructured":"Antebi B, Rodriguez LA, Walker KP, et al. Short-Term Physiological Hypoxia Potentiates the Therapeutic Function of Mesenchymal Stem Cells. Stem Cell Res Ther. 2018;9(1):265.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"5000_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, et al. Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide. Cell Stem Cell. 2008;2(2):141\u201350.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"5000_CR54","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, et al. A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype. PLoS ONE. 2010;5(4):e10088.","journal-title":"PLoS ONE"},{"issue":"5","key":"5000_CR55","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s12015-020-10000-1","volume":"16","author":"AK Varkouhi","year":"2020","unstructured":"Varkouhi AK, Monteiro APT, Tsoporis JN, et al. Genetically Modified Mesenchymal Stromal\/Stem Cells: Application in Critical Illness. Stem Cell Reviews Rep. 2020;16(5):812\u201327.","journal-title":"Stem Cell Reviews Rep"},{"issue":"7","key":"5000_CR56","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou M, Huang L, Yang J, et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles for Immunomodulation and Regeneration: A next Generation Therapeutic Tool? Cell Death Dis. 2022;13(7):580.","journal-title":"Cell Death Dis"},{"issue":"3","key":"5000_CR57","first-page":"275","volume":"38","author":"Y He","year":"2022","unstructured":"He Y, Ji D, Lu W, et al. [Functional deficiency of bone marrow mesenchymal stem cells in patients with immune thrombocytopenia: An update]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi\u2009=\u2009Chinese. J Cell Mol Immunol. 2022;38(3):275\u201380.","journal-title":"J Cell Mol Immunol"},{"issue":"1","key":"5000_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000517989","volume":"145","author":"Y He","year":"2022","unstructured":"He Y, Ji D, Lu W, et al. The Mechanistic Effects and Clinical Applications of Various Derived Mesenchymal Stem Cells in Immune Thrombocytopenia. Acta Haematol. 2022;145(1):9\u201317.","journal-title":"Acta Haematol"},{"issue":"1","key":"5000_CR59","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13287-023-03323-6","volume":"14","author":"F Wu","year":"2023","unstructured":"Wu F, She Z, Li C, et al. Therapeutic Potential of MSCs and MSC-Derived Extracellular Vesicles in Immune Thrombocytopenia. Stem Cell Res Ther. 2023;14(1):79.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"5000_CR60","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.5966\/sctm.2015-0360","volume":"5","author":"JM Zhang","year":"2016","unstructured":"Zhang JM, Feng FE, Wang QM, et al. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression. Stem Cells Translational Med. 2016;5(12):1631\u201343.","journal-title":"Stem Cells Translational Med"},{"key":"5000_CR61","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1182\/blood-2024-201544","volume":"144","author":"X Cai","year":"2024","unstructured":"Cai X, Wu J, Fu H, et al. Decitabine Regulates the Function of Mesenchymal Stem Cells By Restoring MAGEA4-Mediated Apoptosis in Immune Thrombocytopenia. Blood. 2024;144:2685.","journal-title":"Blood"},{"issue":"8","key":"5000_CR62","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3324\/haematol.2018.204446","volume":"104","author":"X Zhu","year":"2019","unstructured":"Zhu X, Wang Y, Jiang Q, et al. All-Trans Retinoic Acid Protects Mesenchymal Stem Cells from Immune Thrombocytopenia by Regulating the Complement-Interleukin-1\u03b2 Loop. Haematologica. 2019;104(8):1661\u201375.","journal-title":"Haematologica"},{"issue":"3","key":"5000_CR63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjh.15034","volume":"180","author":"Y He","year":"2018","unstructured":"He Y, Xu LL, Feng FE, et al. Mesenchymal Stem Cell Deficiency Influences Megakaryocytopoiesis through the TNFAIP3\/NF-\u03baB\/SMAD Pathway in Patients with Immune Thrombocytopenia. Br J Haematol. 2018;180(3):395\u2013411.","journal-title":"Br J Haematol"},{"key":"5000_CR64","doi-asserted-by":"publisher","first-page":"107602962210935","DOI":"10.1177\/10760296221093595","volume":"28","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Cui S, Wang Y, et al. The Extensive Regulation of MicroRNA in Immune Thrombocytopenia. Clin Appl Thromb Hemost. 2022;28:10760296221093595.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"22","key":"5000_CR65","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1089\/scd.2017.0078","volume":"26","author":"LL Xu","year":"2017","unstructured":"Xu LL, Fu HX, Zhang JM, et al. Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1\/Jagged-1 Signaling Pathway. Stem Cells Dev. 2017;26(22):1648\u201361.","journal-title":"Stem Cells Dev"},{"issue":"2","key":"5000_CR66","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bjh.13292","volume":"169","author":"T Sun","year":"2015","unstructured":"Sun T, Zhang D, Yang Y, et al. Interleukin 35 May Contribute to the Loss of Immunological Self-Tolerance in Patients with Primary Immune Thrombocytopenia. Br J Haematol. 2015;169(2):278\u201385.","journal-title":"Br J Haematol"},{"issue":"9","key":"5000_CR67","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1182\/bloodadvances.2018026690","volume":"3","author":"M Wang","year":"2019","unstructured":"Wang M, Feng R, Zhang JM, et al. Dysregulated Megakaryocyte Distribution Associated with Nestin+ Mesenchymal Stem Cells in Immune Thrombocytopenia. Blood Adv. 2019;3(9):1416\u201328.","journal-title":"Blood Adv"},{"issue":"13","key":"5000_CR68","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/blood.2019000721","volume":"134","author":"B Ramasz","year":"2019","unstructured":"Ramasz B, Kr\u00fcger A, Reinhardt J, et al. Hematopoietic Stem Cell Response to Acute Thrombocytopenia Requires Signaling through Distinct Receptor Tyrosine Kinases. Blood. 2019;134(13):1046\u201358.","journal-title":"Blood"},{"key":"5000_CR69","doi-asserted-by":"publisher","first-page":"118057","DOI":"10.1016\/j.lfs.2020.118057","volume":"257","author":"Y Chang","year":"2020","unstructured":"Chang Y, Chen X, Tian Y, et al. Downregulation of microRNA-155-5p Prevents Immune Thrombocytopenia by Promoting Macrophage M2 Polarization via the SOCS1-Dependent PD1\/PDL1 Pathway. Life Sci. 2020;257:118057.","journal-title":"Life Sci"},{"key":"5000_CR70","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.omtn.2020.04.013","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang J, Su Y, et al. miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K\/Akt and P53 in Immune Thrombocytopenia. Mol Therapy Nucleic Acids. 2020;20:764\u201376.","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"6","key":"5000_CR71","doi-asserted-by":"publisher","first-page":"e70058","DOI":"10.1002\/biof.70058","volume":"51","author":"G Polacchini","year":"2025","unstructured":"Polacchini G, Venerando A, Bigot A, et al. Oleuropein Aglycone Modulates Oxidative Stress and Autophagy-Related Pathways in Human Skeletal Muscle Cells. Biofactors. 2025;51(6):e70058.","journal-title":"Biofactors"},{"issue":"11","key":"5000_CR72","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/jcp.25371","volume":"231","author":"Y Ozkul","year":"2016","unstructured":"Ozkul Y, Galderisi U. The Impact of Epigenetics on Mesenchymal Stem Cell Biology. J Cell Physiol. 2016;231(11):2393\u2013401.","journal-title":"J Cell Physiol"},{"issue":"5","key":"5000_CR73","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10741-020-09929-9","volume":"26","author":"AM Gorabi","year":"2021","unstructured":"Gorabi AM, Kiaie N, Pirro M, et al. Effects of Statins on the Biological Features of Mesenchymal Stem Cells and Therapeutic Implications. Heart Fail Rev. 2021;26(5):1259\u201372.","journal-title":"Heart Fail Rev"},{"issue":"12","key":"5000_CR74","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.intimp.2010.06.019","volume":"10","author":"MJ Hoogduijn","year":"2010","unstructured":"Hoogduijn MJ, Popp F, Verbeek R, et al. The Immunomodulatory Properties of Mesenchymal Stem Cells and Their Use for Immunotherapy. Int Immunopharmacol. 2010;10(12):1496\u2013500.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"5000_CR75","doi-asserted-by":"publisher","first-page":"e2413398122","DOI":"10.1073\/pnas.2413398122","volume":"122","author":"T Kamatani","year":"2025","unstructured":"Kamatani T, Kimura R, Ikeda S, et al. iPSCs Engrafted in Allogeneic Hosts without Immunosuppression Induce Donor-Specific Tolerance to Secondary Allografts. Proc Natl Acad Sci USA. 2025;122(11):e2413398122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5000_CR76","doi-asserted-by":"publisher","first-page":"175412","DOI":"10.1016\/j.ejphar.2022.175412","volume":"938","author":"A Mishra","year":"2023","unstructured":"Mishra A, Pathak Y, Mishra SK, et al. Natural Compounds as a Potential Modifier of Stem Cells Renewal: Comparative Analysis. Eur J Pharmacol. 2023;938:175412.","journal-title":"Eur J Pharmacol"},{"key":"5000_CR77","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/978-1-0716-2772-3_19","volume":"2587","author":"H Hayashita-Kinoh","year":"2023","unstructured":"Hayashita-Kinoh H, Okada T. Use of Mesenchymal Stem Cells to Enhance the Efficacy of Gene Therapy. Methods Mol Biology (Clifton N J). 2023;2587:377\u201386.","journal-title":"Methods Mol Biology (Clifton N J)"},{"issue":"5","key":"5000_CR78","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/bjh.16953","volume":"191","author":"H Li","year":"2020","unstructured":"Li H, Guan Y, Sun B, et al. Role of Bone Marrow-Derived Mesenchymal Stem Cell Defects in CD8\u2009+\u2009CD28- Suppressor T-Lymphocyte Induction in Patients with Immune Thrombocytopenia and Associated Mechanisms. Br J Haematol. 2020;191(5):852\u201362.","journal-title":"Br J Haematol"},{"key":"5000_CR79","doi-asserted-by":"publisher","first-page":"785717","DOI":"10.3389\/fimmu.2021.785717","volume":"12","author":"JM Chen","year":"2021","unstructured":"Chen JM, Huang QY, Zhao YX, et al. The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous. Front Immunol. 2021;12:785717.","journal-title":"Front Immunol"},{"key":"5000_CR80","doi-asserted-by":"crossref","unstructured":"Cai X, Gui RY, Wu J et al. Decreased Expression of IL-35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 2024, 11(12): e2305798.","DOI":"10.1002\/advs.202305798"},{"issue":"5","key":"5000_CR81","doi-asserted-by":"publisher","first-page":"109783","DOI":"10.1016\/j.isci.2024.109783","volume":"27","author":"H Na","year":"2024","unstructured":"Na H, Im KI, Kim N, et al. The IL-6 Signaling Pathway Contributes Critically to the Immunomodulatory Mechanism of Human Decidua-Derived Mesenchymal Stromal Cells. iScience. 2024;27(5):109783.","journal-title":"iScience"},{"key":"5000_CR82","doi-asserted-by":"crossref","unstructured":"Chen Z, Zhou S, Li J et al. SDF-1\u03b1 Facilitates Mesenchymal Stem Cells to Induce Regulatory B Cell Differentiation from Patients with Immune Thrombocytopenia. Stem Cells International, 2021, 2021: 3254488.","DOI":"10.1155\/2021\/3254488"},{"issue":"2","key":"5000_CR83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bjh.18101","volume":"197","author":"B Will","year":"2022","unstructured":"Will B. Effects of Eltrombopag on Mesenchymal Stem Cells in Immune Thrombocytopenia Purpura. Br J Haematol. 2022;197(2):137\u20138.","journal-title":"Br J Haematol"},{"issue":"1","key":"5000_CR84","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/bjh.18012","volume":"197","author":"A Di Paola","year":"2022","unstructured":"Di Paola A, Palumbo G, Tortora C, et al. Eltrombopag in Paediatric Immune Thrombocytopenia: Iron Metabolism Modulation in Mesenchymal Stromal Cells. Br J Haematol. 2022;197(1):110\u20139.","journal-title":"Br J Haematol"},{"key":"5000_CR85","doi-asserted-by":"crossref","unstructured":"Zhang JM, Zhu XL, Xue J, et al. Integrated mRNA and miRNA Profiling Revealed Deregulation of Cellular Stress Response in Bone Marrow Mesenchymal Stem Cells Derived from Patients with Immune Thrombocytopenia. Volume 18. Functional & Integrative Genomics; 2018. pp. 287\u201399. 3.","DOI":"10.1007\/s10142-018-0591-2"},{"issue":"1","key":"5000_CR86","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s13287-025-04736-1","volume":"16","author":"H Jafar","year":"2025","unstructured":"Jafar H, Almousa R, Alhawari H, et al. Human Umbilical Cord Mesenchymal Stromal Cells Derivatives in Treating Diabetic Foot Ulcers: A Phase I\/II Safety and Efficacy Trial. Stem Cell Res Ther. 2025;16(1):657.","journal-title":"Stem Cell Res Ther"},{"key":"5000_CR87","doi-asserted-by":"crossref","unstructured":"Dong H, Ren Z, Shao W et al. Effect of ADSCs on Th17\/Treg and T-Bet\/GATA-3 in Model Mice with Primary Immune Thrombocytopenia. Cellular and Molecular Biology (Noisy-Le-Grand, France), 2024, 70(5): 150\u2013154.","DOI":"10.14715\/cmb\/2024.70.5.21"},{"issue":"10","key":"5000_CR88","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1007\/s00277-025-06652-z","volume":"104","author":"S Pendse","year":"2025","unstructured":"Pendse S, Kale V, Vaidya A. Microvesicles Secreted by CoCl2-Primed Mesenchymal Stromal Cells Boost the Functionality of Hematopoietic Stem Cells Cultured with Them. Ann Hematol. 2025;104(10):5389\u2013402.","journal-title":"Ann Hematol"},{"key":"5000_CR89","doi-asserted-by":"crossref","unstructured":"Fang Y, Chen Y, Yu X, et al. Rg1-Preconditioned Adipose-Derived Mesenchymal Stromal Cells Alleviate Colitis via Exosome-Mediated Inhibition of Macrophage Glycolysis through RAS Signaling. Stem Cell Research & Therapy; 2025.","DOI":"10.1186\/s13287-025-04822-4"},{"key":"5000_CR90","doi-asserted-by":"publisher","first-page":"1662095","DOI":"10.3389\/fbioe.2025.1662095","volume":"13","author":"K Chen","year":"2025","unstructured":"Chen K, Ye W, Chi L, et al. Exosomes Derived from miR-26a-5p-Modified Adipose Mesenchymal Stem Cells Improve Wound Healing by Targeting MAP2K4. Front Bioeng Biotechnol. 2025;13:1662095.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"5000_CR91","first-page":"11","volume":"21","author":"J Chen","year":"2025","unstructured":"Chen J, Lin T, Yuan Y, et al. Comparative Analysis of the Immunomodulatory Functions of Dental Follicle Stem Cells and Their Apoptotic Vesicles. J Stem Cells Regenerative Med. 2025;21(1):11\u20138.","journal-title":"J Stem Cells Regenerative Med"},{"issue":"12","key":"5000_CR92","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1111\/j.1537-2995.2012.03642.x","volume":"52","author":"J Xiao","year":"2012","unstructured":"Xiao J, Zhang C, Zhang Y, et al. Transplantation of Adipose-Derived Mesenchymal Stem Cells into a Murine Model of Passive Chronic Immune Thrombocytopenia. Transfusion. 2012;52(12):2551\u20138.","journal-title":"Transfusion"},{"issue":"7","key":"5000_CR93","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/TP.0000000000005309","volume":"109","author":"CG Avalos-de Leon","year":"2025","unstructured":"Avalos-de Leon CG, Thomson AW. Regulatory Immune Cell-Derived Exosomes: Modes of Action and Therapeutic Potential in Transplantation. Transplantation. 2025;109(7):1124\u201337.","journal-title":"Transplantation"},{"issue":"1","key":"5000_CR94","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12038-020-00068-9","volume":"45","author":"A Mohanty","year":"2020","unstructured":"Mohanty A, Polisetti N, Vemuganti GK. Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells. J Biosci. 2020;45(1):98.","journal-title":"J Biosci"},{"issue":"11","key":"5000_CR95","doi-asserted-by":"publisher","first-page":"e0335011","DOI":"10.1371\/journal.pone.0335011","volume":"20","author":"AM Khalid Ahmed","year":"2025","unstructured":"Khalid Ahmed AM, Khalaf Ali M, Kh Alani B. The Effect of Therapeutic Potential and Safety of Bone Marrow-Derived against Adipose-Derived Mesenchymal Stem Cells in Aged Mice Associated with Septic Arthritis. PLoS ONE. 2025;20(11):e0335011.","journal-title":"PLoS ONE"},{"key":"5000_CR96","unstructured":"Arif T, Qiu J, Khademian H et al. Reversing Lysosomal Dysfunction Restores Youthful State in Aged Hematopoietic Stem Cells. Cell Stem Cell, 2025: S1934-5909(25)00405\u20139."},{"issue":"1","key":"5000_CR97","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10522-025-10353-5","volume":"27","author":"A Salminen","year":"2025","unstructured":"Salminen A, Kaarniranta K, Kauppinen A. Activation of cGAS-STING Signaling in Senescent Cells Promotes the Aging Process by Remodeling the Functions of the Immune System. Biogerontology. 2025;27(1):4.","journal-title":"Biogerontology"},{"issue":"1","key":"5000_CR98","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1186\/s13287-025-04792-7","volume":"16","author":"M Sheykhhasan","year":"2025","unstructured":"Sheykhhasan M, Yang P, Yaghoubi SM, et al. Therapeutic Potential and Mechanistic Insights into Adipose-Derived Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients with Crohn\u2019s Disease-Associated Fistulas: Challenges and Future Perspectives. Stem Cell Res Ther. 2025;16(1):664.","journal-title":"Stem Cell Res Ther"},{"key":"5000_CR99","unstructured":"Tertel T, Giebel B, Lee RH, et al. ISCT 2025 Exosomes Signature Series: A Thematic Synthesis for Advancing MSC EV Therapies. Volume 0. Cytotherapy, Elsevier,; 2025. 0."},{"issue":"7","key":"5000_CR100","doi-asserted-by":"publisher","first-page":"11274","DOI":"10.1002\/jcb.28405","volume":"120","author":"P Zhang","year":"2019","unstructured":"Zhang P, Zhang G, Liu X, et al. Mesenchymal Stem Cells Improve Platelet Counts in Mice with Immune Thrombocytopenia. J Cell Biochem. 2019;120(7):11274\u201383.","journal-title":"J Cell Biochem"},{"issue":"1","key":"5000_CR101","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13577-024-01162-y","volume":"38","author":"Y Rong","year":"2024","unstructured":"Rong Y, Lu W, Huang X, et al. Exosomal miR-146a-5p Derived from Bone Marrow Mesenchymal Stromal Cells Regulate Th1\/Th2 Balance and Alleviates Immune Thrombocytopenia in Pregnancy. Hum Cell. 2024;38(1):31.","journal-title":"Hum Cell"},{"key":"5000_CR102","doi-asserted-by":"crossref","unstructured":"Fang B, Song YP, Li N et al. Resolution of Refractory Chronic Autoimmune Thrombocytopenic Purpura Following Mesenchymal Stem Cell Transplantation: A Case Report. Transplantation Proceedings, 2009, 41(5): 1827\u20131830.","DOI":"10.1016\/j.transproceed.2008.12.031"},{"issue":"1","key":"5000_CR103","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1186\/s12884-025-08177-9","volume":"25","author":"T Tong","year":"2025","unstructured":"Tong T, Wu L, Shi H, et al. Mesenchymal Stem Cells Therapy for Immune Thrombocytopenia in Pregnancy: A Case Report. BMC Pregnancy Childbirth. 2025;25(1):1038.","journal-title":"BMC Pregnancy Childbirth"},{"key":"5000_CR104","doi-asserted-by":"crossref","unstructured":"Gao F, Chiu SM, Motan DaL et al. Mesenchymal Stem Cells and Immunomodulation: Current Status and Future Prospects. Cell Death & Disease, Nature Publishing Group, 2016, 7(1): e2062\u2013e2062.","DOI":"10.1038\/cddis.2015.327"},{"key":"5000_CR105","doi-asserted-by":"publisher","first-page":"1010399","DOI":"10.3389\/fimmu.2022.1010399","volume":"13","author":"M Sarsenova","year":"2022","unstructured":"Sarsenova M, Kim Y, Raziyeva K, et al. Recent Advances to Enhance the Immunomodulatory Potential of Mesenchymal Stem Cells. Front Immunol. 2022;13:1010399.","journal-title":"Front Immunol"},{"issue":"11","key":"5000_CR106","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chen X, Cao W, et al. Plasticity of Mesenchymal Stem Cells in Immunomodulation: Pathological and Therapeutic Implications. Nat Immunol. 2014;15(11):1009\u201316.","journal-title":"Nat Immunol"},{"key":"5000_CR107","doi-asserted-by":"crossref","unstructured":"Rj T, Sn S, Xy Z et al. Mesenchymal Stem Cells-Regulated Treg Cells Suppress Colitis-Associated Colorectal Cancer. Stem cell research & therapy. Stem Cell Res Ther, 2015, 6(1).","DOI":"10.1186\/s13287-015-0055-8"},{"issue":"1","key":"5000_CR108","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13287-019-1156-6","volume":"10","author":"L Salda\u00f1a","year":"2019","unstructured":"Salda\u00f1a L, Bensiamar F, Vall\u00e9s G, et al. Immunoregulatory Potential of Mesenchymal Stem Cells Following Activation by Macrophage-Derived Soluble Factors. Stem Cell Res Ther. 2019;10(1):58.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5000_CR109","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13287-023-03323-6","volume":"14","author":"F Wu","year":"2023","unstructured":"Wu F, She Z, Li C, et al. Therapeutic Potential of MSCs and MSC-Derived Extracellular Vesicles in Immune Thrombocytopenia. Stem Cell Res Ther. 2023;14(1):79.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"5000_CR110","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.3390\/ijms23084462","volume":"23","author":"O Kandarakov","year":"2022","unstructured":"Kandarakov O, Belyavsky A, Semenova E. Bone Marrow Niches of Hematopoietic Stem and Progenitor Cells. Int J Mol Sci. 2022;23(8):4462.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5000_CR111","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/jcm9030856","volume":"9","author":"AK Batsali","year":"2020","unstructured":"Batsali AK, Georgopoulou A, Mavroudi I, et al. The Role of Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles (MSC-EVs) in Normal and Abnormal Hematopoiesis and Their Therapeutic Potential. J Clin Med. 2020;9(3):856.","journal-title":"J Clin Med"},{"issue":"1","key":"5000_CR112","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13287-022-02875-3","volume":"13","author":"DP Sarvar","year":"2022","unstructured":"Sarvar DP, Effatpanah H, Akbarzadehlaleh P, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles: Novel Approach in Hematopoietic Stem Cell Transplantation. Stem Cell Res Ther. 2022;13(1):202.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5000_CR113","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13287-018-1104-x","volume":"10","author":"J Ma","year":"2019","unstructured":"Ma J, Wu J, Han L, et al. Comparative Analysis of Mesenchymal Stem Cells Derived from Amniotic Membrane, Umbilical Cord, and Chorionic Plate under Serum-Free Condition. Stem Cell Res Ther. 2019;10(1):19.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5000_CR114","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1038\/s41598-025-32738-9","volume":"16","author":"M \u00c7opuro\u011flu","year":"2025","unstructured":"\u00c7opuro\u011flu M, Yal\u00e7\u0131n \u00d6T, Kara SG. Clinical Feasibility and Cost Efficiency of Perinatal Mesenchymal Stem Cell Production under GMP Conditions. Sci Rep. 2025;16(1):2791.","journal-title":"Sci Rep"},{"key":"5000_CR115","doi-asserted-by":"crossref","unstructured":"Li Cyu, Wu X, yun, Tong J et al. bei,. Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow and Adipose Tissue under Xeno-Free Conditions for Cell Therapy. Stem Cell Research & Therapy, 2015, 6(1): 55.","DOI":"10.1186\/s13287-015-0066-5"},{"key":"5000_CR116","doi-asserted-by":"crossref","unstructured":"Kern S, Eichler H, Stoeve J et al. Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue. Stem Cells, Dayton, Ohio: 2006, 24(5): 1294\u20131301.","DOI":"10.1634\/stemcells.2005-0342"},{"issue":"1","key":"5000_CR117","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/ijmm.2015.2413","volume":"37","author":"JS Heo","year":"2016","unstructured":"Heo JS, Choi Y, Kim HS, et al. Comparison of Molecular Profiles of Human Mesenchymal Stem Cells Derived from Bone Marrow, Umbilical Cord Blood, Placenta and Adipose Tissue. Int J Mol Med. 2016;37(1):115\u201325.","journal-title":"Int J Mol Med"},{"key":"5000_CR118","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13287-025-04880-8","volume":"17","author":"M Deng","year":"2025","unstructured":"Deng M, Zhang X, Zhang Y. The Roles and Clinical Applications of Mesenchymal Stem Cells and Their Exosomes in Hematologic Diseases. Stem Cell Res Ther. 2025;17:51.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"5000_CR119","doi-asserted-by":"publisher","first-page":"11274","DOI":"10.1002\/jcb.28405","volume":"120","author":"P Zhang","year":"2019","unstructured":"Zhang P, Zhang G, Liu X, et al. Mesenchymal Stem Cells Improve Platelet Counts in Mice with Immune Thrombocytopenia. J Cell Biochem. 2019;120(7):11274\u201383.","journal-title":"J Cell Biochem"},{"issue":"1","key":"5000_CR120","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s40001-023-01244-x","volume":"28","author":"T Lin","year":"2023","unstructured":"Lin T, Yang Y, Chen X. A Review of the Application of Mesenchymal Stem Cells in the Field of Hematopoietic Stem Cell Transplantation. Eur J Med Res. 2023;28(1):268.","journal-title":"Eur J Med Res"},{"issue":"6","key":"5000_CR121","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2174\/1574888X18666230811093101","volume":"19","author":"D Ti","year":"2024","unstructured":"Ti D, Yi J, Chen H, et al. The Role of Mesenchymal Stem\/Stromal Cells Secretome in Macrophage Polarization: Perspectives on Treating Inflammatory Diseases. Curr Stem Cell Res Therapy. 2024;19(6):894\u2013905.","journal-title":"Curr Stem Cell Res Therapy"},{"key":"5000_CR122","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21037\/sci-2020-036","volume":"8","author":"AP Aithal","year":"2021","unstructured":"Aithal AP, Bairy LK, Seetharam RN. Safety and Therapeutic Potential of Human Bone Marrow-Derived Mesenchymal Stromal Cells in Regenerative Medicine. Stem Cell Invest. 2021;8:10.","journal-title":"Stem Cell Invest"},{"key":"5000_CR123","doi-asserted-by":"publisher","first-page":"096368972312132","DOI":"10.1177\/09636897231213271","volume":"32","author":"Z Liang","year":"2023","unstructured":"Liang Z, Zhang G, Gan G, et al. Preclinical Short-Term and Long-Term Safety of Human Bone Marrow Mesenchymal Stem Cells. Cell Transplant. 2023;32:09636897231213271.","journal-title":"Cell Transplant"},{"issue":"13","key":"5000_CR124","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","volume":"69","author":"GV R\u00f8sland","year":"2009","unstructured":"R\u00f8sland GV, Svendsen A, Torsvik A, et al. Long-Term Cultures of Bone Marrow-Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation. Cancer Res. 2009;69(13):5331\u20139.","journal-title":"Cancer Res"},{"issue":"9","key":"5000_CR125","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/sctm.17-0031","volume":"6","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, J\u00f8rgensen MG, Tabatabaeifar S, et al. Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events. Stem Cells Translational Med. 2017;6(9):1786\u201394.","journal-title":"Stem Cells Translational Med"},{"issue":"7","key":"5000_CR126","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.2337\/db15-0162","volume":"64","author":"A Eljaafari","year":"2015","unstructured":"Eljaafari A, Robert M, Chehimi M, et al. Adipose Tissue-Derived Stem Cells From Obese Subjects Contribute to Inflammation and Reduced Insulin Response in Adipocytes Through Differential Regulation of the Th1\/Th17 Balance and Monocyte Activation. Diabetes. 2015;64(7):2477\u201388.","journal-title":"Diabetes"},{"issue":"1","key":"5000_CR127","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/stcltm\/szab005","volume":"11","author":"G Moll","year":"2022","unstructured":"Moll G, Ankrum JA, Olson SD, et al. Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products. Stem Cells Translational Med. 2022;11(1):2\u201313.","journal-title":"Stem Cells Translational Med"},{"issue":"4","key":"5000_CR128","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/stcltm\/szae003","volume":"13","author":"C Hum","year":"2024","unstructured":"Hum C, Tahir U, Mei SHJ, et al. Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cell Therapy in Preclinical Models of Sepsis: A Systematic Review and Meta-Analysis. Stem Cells Translational Med. 2024;13(4):346\u201361.","journal-title":"Stem Cells Translational Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05000-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05000-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05000-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:02:42Z","timestamp":1779210162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05000-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5000"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05000-w","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}